In this report, we describe the case of an elderly female patient known with hepatitis C virus (HCV) infection since 2001 and treated with direct-acting antiviral drugs in 2017 for HCV cirrhosis, incidentally diagnosed with PMF and type 1 CALR mutation, who exhibited an accelerated progression to refractory sAML. This evidence concerns the gene CALR and Cirrhosis.